Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1852755804;55805;55806 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
N2AB1688650881;50882;50883 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
N2A1595948100;48101;48102 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
N2B946228609;28610;28611 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
Novex-1958728984;28985;28986 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
Novex-2965429185;29186;29187 chr2:178601418;178601417;178601416chr2:179466145;179466144;179466143
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Fn3-22
  • Domain position: 49
  • Structural Position: 66
  • Q(SASA): 0.586
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I rs1344009252 0.134 0.211 N 0.262 0.164 0.252162846088 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 5.63E-05 None 0 None 0 0 0
T/I rs1344009252 0.134 0.211 N 0.262 0.164 0.252162846088 gnomAD-4.0.0 6.8458E-06 None None None None N None 2.9915E-05 0 None 0 2.27687E-04 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1091 likely_benign 0.1247 benign -0.643 Destabilizing 0.64 D 0.474 neutral N 0.49681545 None None N
T/C 0.4549 ambiguous 0.5046 ambiguous -0.451 Destabilizing 0.999 D 0.599 neutral None None None None N
T/D 0.6686 likely_pathogenic 0.6789 pathogenic 0.164 Stabilizing 0.988 D 0.559 neutral None None None None N
T/E 0.4534 ambiguous 0.4588 ambiguous 0.154 Stabilizing 0.988 D 0.561 neutral None None None None N
T/F 0.3948 ambiguous 0.4656 ambiguous -0.75 Destabilizing 0.988 D 0.627 neutral None None None None N
T/G 0.2725 likely_benign 0.314 benign -0.877 Destabilizing 0.034 N 0.315 neutral None None None None N
T/H 0.3499 ambiguous 0.3985 ambiguous -1.043 Destabilizing 0.999 D 0.647 neutral None None None None N
T/I 0.1912 likely_benign 0.2209 benign -0.122 Destabilizing 0.211 N 0.262 neutral N 0.487638607 None None N
T/K 0.3066 likely_benign 0.357 ambiguous -0.594 Destabilizing 0.988 D 0.565 neutral None None None None N
T/L 0.1245 likely_benign 0.1488 benign -0.122 Destabilizing 0.851 D 0.44 neutral None None None None N
T/M 0.1053 likely_benign 0.1278 benign -0.062 Destabilizing 0.997 D 0.595 neutral None None None None N
T/N 0.167 likely_benign 0.1731 benign -0.497 Destabilizing 0.968 D 0.521 neutral N 0.520903031 None None N
T/P 0.6647 likely_pathogenic 0.7809 pathogenic -0.263 Destabilizing 0.995 D 0.595 neutral N 0.494259206 None None N
T/Q 0.2435 likely_benign 0.2648 benign -0.622 Destabilizing 0.996 D 0.591 neutral None None None None N
T/R 0.2913 likely_benign 0.3676 ambiguous -0.349 Destabilizing 0.988 D 0.595 neutral None None None None N
T/S 0.1389 likely_benign 0.1436 benign -0.786 Destabilizing 0.896 D 0.459 neutral N 0.456123621 None None N
T/V 0.1301 likely_benign 0.1439 benign -0.263 Destabilizing 0.851 D 0.447 neutral None None None None N
T/W 0.7607 likely_pathogenic 0.8123 pathogenic -0.715 Destabilizing 0.999 D 0.689 prob.neutral None None None None N
T/Y 0.4281 ambiguous 0.5037 ambiguous -0.473 Destabilizing 0.996 D 0.635 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.